Positron is committed to expanding the cardiac and oncology PET modality by delivering the best technology and value to imaging specialists and will continue to advance its technology through its ...

Pulse Biosciences is developing nsPFA technology for cardiac ablation to treat AFib and for ablating benign thyroid nodules.

As the chief information officer at Reid Health, I’ve seen firsthand how administrative burdens are driving clinician burnout ...

If we want to create a modern and personalized healthcare experience, the doctor’s office is just the tip of the iceberg. The ...

The global positron emission tomography (PET) scanners market is expected to reach USD 1,441.5 million by 2025 and market is projected to steadily grow at a compound annual growth rate (CAGR) of 5.3%, ...

Artificial intelligence offers breakthroughs in life sciences, yet issues of bias, interpretability, and ethics pose ...